FREQ - Moore Kuehn PLLC Encourages Investors of FREQ to Contact Law Firm
New York, New York--(Newsfile Corp. - August 12, 2021) - Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating potential claims involving directors and officers regarding possible breaches of fiduciary duties related to whether insiders caused their companies to make false and/or misleading statements and/or failed to disclose, among other things, that:
• Frequency Therapeutics Inc. (NASDAQ: FREQ)
The company or its officers and directors made materially false and misleading statements and/or failed to disclose that: (1) Frequency's development and commercialization of a hearing loss treatment titled "FX-322" was not producing the results desired by Frequency; (2) FX-322's ongoing clinical study was not as positive as Frequency portrayed it; and (3) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
If you own FREQ, please contact Fletcher Moore, Esq. by email at fmoore@moorekuehn.com or telephone at (212) 709-8245. There is no cost to you. Moore Kuehn is a New York-based law firm with attorneys representing investors and consumers.
Please visit http://www.moorekuehn.com/practice/new-york-shareholder-derivative-litigation/
Attorney advertising. Prior results do not guarantee similar outcomes.
Moore Kuehn, PLLC
Fletcher Moore, Esq.
30 Wall Street, 8th Floor
New York, New York 10005
fmoore@moorekuehn.com
(212) 709-8245
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/92999